HAO (Haoxi Health Technology) Operating Income: $-7.55 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HAO Haoxi Health Technology Ltd HAO
21 GF Score
Price $3.84
! 5 Warning Signs
View Full Analysis

What is Haoxi Health Technology Operating Income?

Haoxi Health Technology HAO -13.51% 21 Operating Income is $-7.55 Mil as of Dec. 2025. GuruFocus rates HAO with a GF Score™ of 21/100. The stock has 5 warning signs investors should review.

Haoxi Health Technology's Operating Income for the six months ended in Dec. 2025 was $-5.68 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was $-7.55 Mil.

Warning Sign:

Haoxi Health Technology Ltd has recorded a loss in operating income at least once over the past 3 years.

Operating Margin % is calculated as Operating Income divided by its Revenue. Haoxi Health Technology's Operating Income for the six months ended in Dec. 2025 was $-5.68 Mil. Haoxi Health Technology's Revenue for the six months ended in Dec. 2025 was $33.83 Mil. Therefore, Haoxi Health Technology's Operating Margin % for the quarter that ended in Dec. 2025 was -16.79%.

Haoxi Health Technology's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Haoxi Health Technology's annualized ROC % for the quarter that ended in Dec. 2025 was -97.08%. Haoxi Health Technology's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -303.31%.

Haoxi Health Technology  (NAS:HAO) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Haoxi Health Technology's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-11.358 * ( 1 - 0% )/( (11.421 + 11.978)/ 2 )
=-11.358/11.6995
=-97.08 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=21.595 - 1.556 - ( 8.618 - max(0, 3.885 - 19.605+8.618))
=11.421

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=20.661 - 1.882 - ( 6.801 - max(0, 4.438 - 15.323+6.801))
=11.978

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Haoxi Health Technology's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-13.03/( ( (0.188 + max(3.963, 0)) + (0.144 + max(4.297, 0)) )/ 2 )
=-13.03/( ( 4.151 + 4.441 )/ 2 )
=-13.03/4.296
=-303.31 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.46 + 0 + 5.701) - (1.556 + 0.538 + 0.104)
=3.963

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.027 + 0 + 7.377) - (1.882 + 1.224 + 0.00099999999999945)
=4.297

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Haoxi Health Technology's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-5.679/33.828
=-16.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

Haoxi Health Technology Operating Income Related Terms

Haoxi Health Technology Operating Income Historical Data

* Premium members only.

The historical data trend for Haoxi Health Technology's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Haoxi Health Technology Operating Income Chart

Haoxi Health Technology Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Operating Income
0.33 0.27 1.20 1.72 -2.00

Haoxi Health Technology Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.82 0.90 -0.13 -1.87 -5.68
HAO
21GF Score
Haoxi Health Technology Ltd HAO
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Haoxi Health Technology Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-7.55 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of $-7.55 Mil mean?
Haoxi Health Technology (HAO) has a Operating Income of $-7.55 Mil as of Dec. 2025. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Haoxi Health Technology and its competitors.
Is Haoxi Health Technology's Operating Income too high?
Haoxi Health Technology's current Operating Income is $-7.55 Mil. Overall, Haoxi Health Technology has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Haoxi Health Technology's Operating Income compare to BAOS and DBMM?
Haoxi Health Technology's Operating Income of $-7.55 Mil can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Media - Diversified company?
A good Operating Income depends on the Media - Diversified industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Haoxi Health Technology and its competitors. Haoxi Health Technology's current Operating Income is $-7.55 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haoxi Health Technology stock overvalued right now?
Haoxi Health Technology (HAO) has a current Operating Income of $-7.55 Mil. The current Operating Income is $-7.55 Mil. Haoxi Health Technology's overall GF Score™ is 21/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Haoxi Health Technology (HAO), the current Operating Income is $-7.55 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Haoxi Health Technology Business Description

Address Room 801, Tower C, Floor 8, Building 103, Huizhongli, Chaoyang District, Beijing, CHN
Haoxi Health Technology Ltd is an online marketing solution provider in China, with an advertiser client base mainly in the healthcare industry. The company offers services that include planning, producing, placing, and optimizing online ads especially online short video ads, to help its advertisers acquire, convert, and retain ultimate consumers on various online media platforms. It places advertisements on popular digital platforms such as Toutiao, Douyin, WeChat, and Sina Weibo through media partners. Revenue is generated by providing comprehensive online marketing solutions. The company's operations center on digital advertising via mainstream video and social media channels in the Chinese market.
21GF Score

Get the complete analysis for HAO

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.84
Price